Open-label trial on efficacy of artemether/lumefantrine against the uncomplicated Plasmodium falciparum malaria in Metema district, Northwestern Ethiopia

PURPOSE: Following the increased Plasmodium falciparum resistance to chloroquine and sulfadoxine/pyrimethamine, Ethiopia adopted artemether/lumefantrine (AL) as the first-line treatment for uncomplicated P. falciparum in 2004. According to the recommendation of the World Health Organization, this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Wudneh, Feven, Assefa, Ashenafi, Nega, Desalegn, Mohammed, Hussien, Solomon, Hiwot, Kebede, Tadesse, Woyessa, Adugna, Assefa, Yibeltal, Kebede, Amha, Kassa, Moges
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005000/
https://www.ncbi.nlm.nih.gov/pubmed/27601913
http://dx.doi.org/10.2147/TCRM.S113603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005000/
https://www.ncbi.nlm.nih.gov/pubmed/27601913
http://dx.doi.org/10.2147/TCRM.S113603

Ejemplares similares